Short- and Long-Term Efficacy of Combined Cabergoline and Octreotide Treatment in Controlling IGF-I Levels in Acromegaly

Publisher： Karger

E-ISSN： 1423-0194|92|2|120-127

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.92, Iss.2, 2010-08, pp. : 120-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Treatment of Growth Hormone Insensitivity Syndrome with IGF-I

By  

Hormone Research in Paediatrics, Vol. 51, Iss. 3, 1999-08 ,pp. : 128-134

Karger

Access to resources Recommend Favorite

Analyses from a Centre of Short- and Long-Term Growth in Turner’s Syndrome on Standard Growth Hormone Doses Confirm Growth Prediction Algorithms and Show Normal IGF-I Levels

By  

Hormone Research in Paediatrics, Vol. 77, Iss. 4, 2012-03 ,pp. : 214-221

Karger

Access to resources Recommend Favorite

Optimizing Medical Therapy of Acromegaly: Beneficial Effects of Cabergoline in Patients Uncontrolled with Long-Acting Release Octreotide

By  

Neuroendocrinology, Vol. 90, Iss. 1, 2009-05 ,pp. : 82-92

Karger

Access to resources Recommend Favorite

Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable Event

By  

Neuroendocrinology, Vol. 104, Iss. 3, 2016-05 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

Longitudinal Data for Intrauterine Levels of Fetal IGF-I and IGF-II

By  

Hormone Research in Paediatrics, Vol. 61, Iss. 4, 2004-03 ,pp. : 200-204

Karger

Access to resources Recommend Favorite